Ticker Details
Recursion Pharmaceuticals, Inc.
IPO Date:	April 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 4.34%
Avg Daily Range (30 D):	$0.13 | 3.91%
Avg Daily Range (90 D):	$0.10 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	9.07M
Avg Daily Volume (30 D):	21.67M
Avg Daily Volume (90 D):	15.4M

Trade Size
Avg Trade Size (Sh.):	248
Avg Trade Size (Sh.) (30 D):	373
Avg Trade Size (Sh.) (90 D):	315

Institutional Trades
Total Institutional Trades:	2,945
Avg Institutional Trade:	$2.28M
Avg Institutional Trade (30 D):	$3.15M
Avg Institutional Trade (90 D):	$2.51M
Avg Institutional Trade Volume:	.33M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.96M
Avg Closing Trade (30 D):	$5.61M
Avg Closing Trade (90 D):	$4.18M
Avg Closing Volume:	582.46K

News

Jul 10, 2026 @ 2:55 PM Generative AI in Drug Discovery: Revolutionizing P... Source: Researchandmarkets.Com

Jul 5, 2026 @ 10:03 AM Cathie Wood Goes Bargain Hunting: 3 Stocks She Jus... Source: Rick Munarriz

Jul 3, 2026 @ 3:14 PM Moderna vs. Recursion: Which Cutting-Edge Pharma S... Source: Brendan Coffey

Jun 27, 2026 @ 11:23 AM Nvidia Owns This Under-the-Radar $20 Stock Poised ... Source: James Brumley

Jun 26, 2026 @ 4:15 AM 2 Beaten-Down Artificial Intelligence (AI) Stocks ... Source: Prosper Junior Bakiny

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.16	$-.22	$-.17
Diluted EPS	$-1.16	$-.22	$-.17
Revenue	$66.41M	$6.47M	$35.54M
Gross Profit	$4.8M	$-6.02M	$21.26M
Net Income / Loss	$-559.78M	$-117.5M	$-108.12M
Operating Income / Loss	$-585.27M	$-128.51M	$-108.33M
Cost of Revenue	$61.61M	$12.49M	$14.28M
Net Cash Flow	$156.02M	$-88.74M	$86.78M
PE Ratio